Jorge Jure is an experienced Product Manager in the neuroscience sector, currently serving Lundbeck LATAM since December 2021, where responsibilities include developing and executing brand strategies for Rexulti in Major Depressive Disorder and Schizophrenia. Prior to this role, Jorge held the position of Product Manager at Ipsen, focusing on Neurotoxin Dysport for various therapeutic indications in the Mexican market, and at Takeda, managing marketing strategies for Vyvanse. Additionally, earlier experiences include roles at Johnson & Johnson, Merck, UCB Pharma, and sanofi-aventis, where responsibilities ranged from pricing analysis to global marketing communications. Jorge Jure holds an MBA from Loughborough Business School and a degree in Communication from Universidad Nacional Autónoma de México.